
The vaccine, which was rolled out in a national immunization program that began Dec. 20, was 89.4% effective at preventing laboratory-confirmed infections, according to a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the work.
The companies and Israel’s Health Ministry worked together on the preliminary observational analysis, which has not yet been peer-reviewed. Nearly half of the population has had at least one dose of vaccine. Separately, Israeli authorities on Saturday said the Pfizer-BioNTech shot was 99% effective at preventing deaths from the virus.
Discover more from The Randy Report
Subscribe to get the latest posts sent to your email.